DR. Amin ElTigani

Consultant - Medical Oncology

Department of Medicine

Prince Mohammed Bin Abdulaziz Hospital

Ministry of National Guard – Health Affairs

Al Madinah

Kingdom of Saudi Arabia

09 : 45 – 09 : 55

24 June | 2023 Day 2

Primary analysis of TROPHY-U-01 cohort 2, a phase 2 study of sacituzumab govitecan (SG) in platinum (PT)-ineligible patients (pts) with metastatic urothelial cancer (mUC) that progressed after prior checkpoint inhibitor (CPI) therapy.